n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, November 28th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Star Gold Corp. (SRGZ)

The Bull Report, Penny Stock Rumble, SmallCapFinancialWire, Whitehotstocks, Perfect Penny Stocks, Simply Best Penny Stocks, and PennyOmega reported previously on Star Gold Corp. (SRGZ), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets Group’s OTCQB, Star Gold Corp. is a gold exploration/development company. It engages in the acquisition and exploration of precious metal deposit properties and advancing them toward production. The Company has 125 unpatented claims within the Walker Lane belt. Star Gold is now centering on developing its flagship Longstreet Property (Nye County). Star Gold has its corporate headquarters in Coeur d'Alene, Idaho, and its operations office in Tonopah, Nevada.

The Longstreet Property was discovered in the early 1900's. Since obtaining the option to the Longstreet Property, Star Gold has drilled roughly 60 holes on the Main Zone. Four holes were core drilling and the rest were reverse circulation.

The Main Target has a mineable pit designed with low operating expenses. There is substantial expansion of pit potential. The Longstreet site plan includes eight distinct targets.

The Longstreet Mineral Resources are contained in a conceptual open pit. They comprise roughly 84 percent of the worldwide Mineral Resources, with an ore-to-waste strip ratio of 1:0.56.

This past August, Star Gold announced that it entered into the second of two separate agreements securing water allocation rights for its Longstreet Project. Each agreement provides for an option to lease water rights for mining purposes.

Star Gold President, Mr. David Segelov, stated in August, "With the execution of these two water rights agreements, Star Gold is able to tick off another requirement on the pathway to an approved Plan of Operations and Environmental Impact Statement (EIS) for its proposed mine at Longstreet.”

Star Gold has two remaining processes to complete before first filing a Plan of Operations with the United States Forest Service (USFS), and subsequently producing an EIS. This includes completing a baseline hydrological study of the project area that includes drilling to locate depth to the water table.

It also includes completing basic engineering and design for the proposed mine and leach pads. This information will be amassed with other baseline and design information into the overall Plan of Operations.

Star Gold Corp. (SRGZ), closed Tuesday's trading session at $0.0535, down 4.46%, on 7,500 volume with 1 trade. The average volume for the last 60 days is 4,193 and the stock's 52-week low/high is $0.0383/$0.16.

U3O8 Corp. (UWEFF)

InvestorIntel and Streetwise Reports reported on U3O8 Corp. (UWEFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

U3O8 Corp. focuses on the exploration and development of deposits of uranium and associated commodities in South America. The Company's mineral resources estimates were made in accordance with National Instrument 43-101 (NI-43-101). They are contained in three deposits. U3O8 has its corporate office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

Regarding the three deposits, one is the Laguna Salada Deposit, Argentina. A Preliminary Economic Assessment (PEA) shows this near surface, free-digging uranium-vanadium deposit has low production-cost potential.

A second deposit is the Berlin Deposit, Colombia. A PEA shows that Berlin has low-cost uranium production potential because of revenue that would be produced from by-products of phosphate, vanadium, nickel, rare earths (yttrium and neodymium) and other metals, which occur within the deposit.

Potential by-products from uranium production include commodities used in the energy storage industry, in the making of batteries, including nickel, vanadium, and phosphate. The Berlin Project is 100 percent-owned by U3O8. The PEA on Berlin estimates that the deposit would produce revenue of US$2.8 billion over the 15-year mine life.

A third deposit is the Kurupung Deposit, Guyana. At Kurupung, a uranium resource has been estimated in four veins within a uranium-zirconium vein system. Resources have been estimated on four veins. Consistent mineralization of the same kind has been intersected in scout drilling of an additional six veins, while yet other veins require initial exploration drilling.

Uranium and zirconium in the Kurupung Batholith has the geological characteristics of “albitite-hosted” deposits. These usually contain resources in the 60 to 130 million pound range at grades of approximately 0.1 percent U3O8. The Company’s management team sees the Kurupung Deposit as having the potential to join the ranks of the larger albitite-hosted deposits known from other parts of the world.

This month, U3O8 outlined how the offer of a C$1 million line of credit by the Company's Founder and Director, Dr. Keith Barron, as well as funds recently raised by U3O8, will be used to undertake proof-of-concept work on the Company’s Laguna Salada uranium-vanadium deposit. The funds permit U308 to do specific test work, which if successful, is likely to considerably improve the economics of Laguna Salada through reducing operating and capital costs from those determined in the positive Preliminary Economic Assessment (PEA) undertaken in 2014.

Dr. Keith Barron, said, “I believe that there is a clear path for U3O8 Corp. to become a uranium and vanadium producer from the Laguna Salada Deposit. To help U3O8 Corp. achieve that goal, I have pledged to support the Company with a convertible debt facility of up to C$1 million to be paid back in shares in a maximum of three years.”

U3O8 Corp. (UWEFF), closed Tuesday's trading session at $0.315, even for the day. The average volume for the last 60 days is 2,618 and the stock's 52-week low/high is $0.0132/$0.4291.

AudioEye, Inc. (AEYE)

Monster Stocks, PennyStocks24, FreeRealTime, Wall Street Mover, Wall Street Resources, BUYINS.NET, and TheMicrocapNews reported previously on AudioEye, Inc. (AEYE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AudioEye, Inc.’s emphasis is on improving the mobility, usability, and accessibility of all Internet-based content. This is through the development, sale, licensing, and use of its proprietary accessibility technologies. The Company’s aim is transforming how the world experiences digital content through building pioneering technology to make all digital content easier to consume and compliant with accessibility standards. OTCQB-listed, AudioEye has offices in Tucson, Arizona; Atlanta, Georgia; and Washington, D.C.

The Company is the creator of the world’s first and only cloud-based cross-platform/cross-browser screen reader solution for web browsing. AudioEye’s focus is to provide solutions that create better and more complete access to the Internet, print, broadcast, and other media. This is regardless of one’s network connection, device, location, or specific abilities.

AudioEye has developed patented Internet content publication and distribution software. This software permits the conversion of any media into an audio-accessible format. It also allows real-time distribution to end-users on any Internet-connected device.

AudioEye has its Ally™ platform. The Ally+ product enables the Company’s clients to reach more customers, build more brand loyalty, keep more customers and secure more repeat business. AudioEye launched its Ally™ platform. This platform provides a complete, multi-layered solution for organizations looking to comply with Section 508 best practices.

Additionally, the Company’s solutions include comprehensive E-Learning and E-Commerce systems, along with a variety of Internet publishing products and services. AudioEye’s technology uses its patented architecture to deliver a fully accessible audio equivalent of a visual website or mobile website in a compliant format that can be navigated, used, interacted with, and transacted from without the use of a monitor or mouse, by individuals with visual impairments.

The AudioEye Platform is an entirely scalable cloud-based solution. For individuals with hearing impairments, AudioEye’s technology provides captioning for websites. Furthermore, the challenges of reaching those with other impairments are addressed by the technology platform.

In October, AudioEye announced that it, in partnership with Global TechPro, LLC, was selected by a large federal agency to provide web usability tools for their public-facing website. The site experiences average monthly visits between 12.9 and 22 million. In addition, this site is accessed by greater than 65,000 federal employees. Global TechPro is a CMMI Level 3, multi-disciplined, professional Information Technology (IT) services firm.

AudioEye announced this month that Mr. Todd Bankofier, Chief Executive Officer, will present at the 10th Annual LD Micro Main Event Conference on Tuesday, December 5, 2017, at 9:00 am Pacific Time. This event will take place at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Moreover, Mr. Bankofier will be available to meet with investors throughout the day.

For Q3 2017 (ended September 30, 2017), AudioEye increased revenue 163 percent year-over-year, to $744,000, versus $283,000 in Q3 of 2016. The Company grew year-to-date revenue by 214 percent versus the same nine-month period of 2016, to $1.9 million.

AudioEye, Inc. (AEYE), closed Tuesday's trading session at $0.12, down 11.11%, on 749,021 volume with 41 trades. The average volume for the last 60 days is 115,463 and the stock's 52-week low/high is $0.095/$0.37.

Gopher Protocol, Inc. (GOPH)

Wall Street Mover, Profitable Trader Authority, PennyTrader, OTCtipReporter, PennyStockScholar, and Integrity Solution IR reported on Gopher Protocol, Inc. (GOPH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Gopher Protocol, Inc. is developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology. The Company provides a mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional features. Its Integrated Circuit (IC), which is called GopherInsight™, and accompanied software, creates a private and secured network for sharing information and adapting to user preferences. This system is self-learning and constantly evolving. A development stage enterprise, Gopher Protocol is based in Santa Monica, California.

Gopher Protocol is developing a real-time, heuristic based, mobile technology. When developed, the mobile technology will comprise a smart microchip, mobile application software and supporting software, which run on a server. The system envisions the creation of a worldwide network.

The Company believes this will be the first system developed using a human, heuristic based analysis engine. The heart of this system will be its advanced microchip that will be able to undergo installation in any mobile device globally. Gopher Protocol expects that this will result in an internal, private network between all mobile devices utilizing the device through providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and more mobile features.

Gopher Protocol has its licensed technology, the Guardian Patch. The new mobile tracking technology will track and protect anything one cares about, with or without GPS (Global Positioning System).

The Guardian Patch is a stick-on tracking device. It protects and tracks everything from a phone to a loved-one or a pet. The Guardian Patch device was conceived as an offshoot of Gopher Protocol’s microchip technology called GopherInsight™.

Earlier this month, Gopher Protocol introduced its "dDrone" technology. This technology utilizes Artificial Intelligence (AI) to create what is believed to be the world's first" Smart Drone." Gopher AI drone technology uses machine learning to give drones advanced flight capabilities.

Gopher's AI drone technology can solve complex problems related to geo-locations, weather conditions, as well as obstacle avoidance. The dDrone AI system is equipped with deep learning, resembling IBM's Watson which permits it to solve complex calculations.

Gopher Protocol announced the release of its Q3 financials on November 20, 2017. This is its first filing following the acquisition and creation of Ugopherservices.

The Company reported earnings for the three months ended September 30, 2017 of $4,471,626 versus $45,000 for the three months ended September 30, 2016. Its total liabilities and stockholder's equity increased from $18,543 for the period ended December 31, 2016 (audited) to $9,380,486 for the period ended September 30, 2017.

Gopher Protocol, Inc. (GOPH), closed Tuesday's trading session at $1.08, up 16.76%, on 566,296 volume with 393 trades. The average volume for the last 60 days is 98,204 and the stock's 52-week low/high is $0.16/$1.30.

Thunder Mountain Gold, Inc. (THMG)

FeedBlitz, Zacks, and MarketWatch reported on Thunder Mountain Gold, Inc. (THMG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Thunder Mountain Gold, Inc. is a junior gold exploration company. It owns interests in many U.S. precious metals projects. The Company’s primary asset is The South Mountain Project. The South Mountain Project is on private and patented land in southern Idaho, just north of the Nevada border. Established in 1935, Thunder Mountain Gold is based in Boise, Idaho.

Thunder Mountain Gold owns 100 percent of the South Mountain Mine. This mine has a land package consisting of around 1,200 acres of mostly private land - both owned outright and leased. A new gold discovery was revealed in 2009 during fieldwork at South Mountain. The Company’s plan of operation for this, subject to business conditions, is to continue to advance the development at the South Mountain Project.

Another key asset of Thunder Mountain Gold is the Trout Creek Project. The Trout Creek target is in the Reese River Valley area south of Battle Mountain, Lander County, Nevada.

This is a grass roots gold target in the Eureka-Battle Mountain trend of central Nevada, now under Joint Exploration Agreement with Newmont USA Limited. This target comprises 60 unpatented lode mining claims. Trout Creek is on an important trend with Newmont's Phoenix Mine and the Gold Acres, Pipeline. The Cortez Mine lies to the southeast.

Thunder Mountain Gold signed an Amendment that modifies and extends the exploration Minerals Lease and Agreement with Newmont USA Limited on the Trout Creek Project. The extension allows it additional time to complete work requirements on the project and lessens the annual work obligations.

Thunder Mountain Gold’s other projects include Clover Mountain. The Company controls 40 unpatented lode mining claims encompassing roughly 800 acres, near Clover Mountain in Owyhee County, Idaho. Furthermore, its West Tonopah Property comprises 8 unpatented lode mining claims totaling 160 acres in the Tonopah Mining District, Esmeralda County, Nevada.

The South Mountain Project remains Thunder Mountain Gold’s emphasis. However, it also continued the exploration and advancement of the Trout Creek Project in 2015. The flagship South Mountain Project was initially mined in the late 1800s.

The South Mountain Claim Group was purchased by Thunder Mountain Gold in 2007 from a private landowner. The main metals at South Mountain are silver, zinc, lead, copper, and gold.

Thunder Mountain Gold, Inc. (THMG), closed Tuesday's trading session at $0.14, even for the day. The average volume for the last 60 days is 8,950 and the stock's 52-week low/high is $0.06/$0.30.

Spotlight Innovation, Inc. (STLT)

Penny Stock Finder, Stock Preacher, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Penny Picks, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Beacon Equity Research, SuperStockTips, InvestorSoup, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. It identifies and acquires rights to unique and proprietary platform technology candidates. The Company’s emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities. Company subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. A pharmaceutical Company, Spotlight Innovation is based in Urbandale, Iowa.

The Company’s mission is to considerably impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates is realized via its extensive relationships with many leading academic institutions and other sources. Spotlight Innovation provides value-added development capability and funding to speed up development progress.

Spotlight provides solutions for healthcare-focused companies commercializing healthcare intellectual property (IP). Spotlight will partner with proven market leaders by way of sale, out-license, or strategic alliance, when commercially significant benchmarks have been achieved.

The Company works to acquire the rights, via acquisition, license, or otherwise, to innovative and proprietary Platform Technology Candidates. In addition, Spotlight works to provide value-added development capability and funding to attain fast IND approval to commence human clinicals for targeted Platform Technology Candidates.

Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive worldwide rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.

Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. Its subsidiary, Celtic Biotech, began Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer utilizing an Intravenous Route of Administration. ImmunoClin Ltd. is the contract research organization (CRO) overseeing the study conduct.

This past August, Spotlight Innovation announced that it entered into a Sponsored Research Agreement with Indiana University. This Agreement is to support research directed by Elliot Androphy, M.D., aimed at developing safe and effective drugs to treat patients with spinal muscular atrophy (SMA). Dr. Androphy is a member of Spotlight Innovation's Scientific Advisory Board and a co-inventor of STL-182, Spotlight Innovation’s lead product candidate for SMA.

Spotlight Innovation has also formed a corporate partnership with University of Iowa Athletics. This will provide ongoing radio and digital media visibility for the Venodol brand and for Venodol Roll-on to Iowa Hawkeyes Football, Men's Basketball and Wrestling fans.

Venodol Roll-on is a new chronic pain relief product from Spotlight Innovation subsidiary Caretta Therapeutics. This product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation. The multi-year partnership was secured on behalf of the University of Iowa by Learfield's Hawkeye Sports Properties, UI Athletics' multimedia rightsholder.

Spotlight Innovation, Inc. (STLT), closed Tuesday's trading session at $0.1299, even for the day, on 4,554 volume with 6 trades. The average volume for the last 60 days is 38,233 and the stock's 52-week low/high is $0.08/$0.80.

Isodiol International, Inc. (ISOLF)

Stockhouse, InvestorsHub, OTC Markets, Investopedia, and Wealth Daily reported on Isodiol International, Inc. (ISOLF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. An international Bioactive Phytoceutical innovator, the Company’s growth strategy includes the development of over-the-counter (OTC) and pharmaceutical drugs, and expanding its phytoceutical portfolio. Isodiol is continuing global expansion into Latin America, Asia, and Europe. OTCQB-listed, Isodiol International is headquartered in Vancouver, British Columbia.

The Company is the market leader in pharmaceutical grade phytochemical compounds. Furthermore, it is the industry leader in the manufacturing and development of phytoceutical consumer products.

Isodiol International is the initiator of numerous firsts for the cannabis industry. This includes commercialization of 99 percent+ pure, bioactive pharmaceutical grade cannabinoids. It also includes micro-encapsulations and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol International produces raw ingredients, consumer packaged goods such as dietary supplements, food and beverages, skin care, and pharmaceutical products for the worldwide healthcare market. Regarding raw ingredients, the Company develops natural phytoceutical derivatives and delivery technologies.

Concerning consumer products, it develops its own family of product brands for retail sale. It also develops white label products and brands for wholesale customers. Pertaining to pharmaceuticals, Isodiol supplies raw phytoceutical ingredients.

Isodiol International Inc announced this month the U.S. sales launch of ImmunAG™. This product is the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, therefore creating greater bioactivity.

Isodiol has acquired worldwide licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.

With this innovative non-systemic delivery system, a topical cream can be applied to the back of the neck (at the hairline). It is subsequently picked up by the free nerve endings in the dermis of the skin for a highly effective delivery of the compound.

Last week, Isodiol International announced that it entered into a definitive agreement in connection with its earlier announced Letter of Intent (LOI) to acquire Bradley’s Bioscience, Inc. Bradley’s is a foremost manufacturer and distributer of hemp oil and nicotine e-liquids.

Mr. Marcos Agramont, Isodiol International’s Chief Executive Officer, said, “The acquisition of Bradley’s Bioscience, a market poised to be a $61.4 billion-dollar industry by 2025 is another major milestone for the Company. Not only does this allow the Company to penetrate a new market, but we are now also able to provide consumers with a safer alternative to smoking. Overall, we believe Bradley’s Bioscience is a perfect fit with Isodiol and our long-term vision and we are very pleased to be moving forward with this agreement.”

Furthermore, Isodiol International has entered into a binding agreement to acquire 100 percent of C3 Global Biosciences (C3GBS). C3GBS is a cause driven organization. Its dedication is to developing sustainable health solutions via the advancement of cannabis science.

Isodiol International, Inc. (ISOLF), closed Tuesday's trading session at $1.26, up 1.08%, on 1,246,348 volume with 756 trades. The average volume for the last 60 days is 221,426 and the stock's 52-week low/high is $0.0513/$1.2468.

graphic

The QualityStocks
Company Corner

graphic
graphic

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0075, up 25.00%, on 4,797,259 volume with 77 trades. The stock’s average daily volume over the past 60 days is 7,433,356 and its 52-week low/high is $0.0059/$0.35.

Grey Cloak Tech Inc. (OTCQB: GRCK) today announced the appointment of Steve Goldberg as Chief Marketing Officer (CMO) to head up marketing for Grey Cloak's new website, CBD.co. Steve brings 10 years of digital marketing experience to the organization.

Grey Cloak Tech, Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, aims to expand into the rapidly growing cannabinoid (CBD) market through the pending acquisition of Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences, based in Denver, Colorado, develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company's CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company's formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The purchase of Eqova Life Sciences would be a natural fit for the company, which has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company's proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases. Disclaimer

Grey Cloak Tech, Inc. Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech Announces Hiring of Stephen Goldberg as New Chief Marketing Officer for CBD.co

Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace

Grey Cloak Tech, Inc. to Introduce CannaBio Salve at MJBizCon in Las Vegas

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.0703, up 19.15%, on 16,001,058 volume with 835 trades. The stock’s average daily volume over the past 60 days is 2,829,045, and its 52-week low/high is $0.002/$0.0995.

PotNetwork Holding, Inc. (POTN) announces the retirement of 300,000,000 common shares held by principal shareholders. This reduction of over half the issued and outstanding common shares will be exchanged for non-trading preferred shares. Upon retirement, this reduction will bring the Company’s current issued and outstanding common shares of 569,920,485 down to a total of 269,920,485 issued and outstanding common shares.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding, Inc. to Retire over 52% of Issued and Outstanding Common Shares

National Radio and Web Broadcast to Feature PotNetwork on R.P. Summit Business Hour on Tuesday, November 21, 2017

PotNetwork Holding, Inc. Reports Revenues of $1,694,788 for October, Surpassing September Results by over Half a Million Dollars

Veritas Pharma, Inc. (CSE:VRT) (OTC:VRTHF) (FRT:2VP)

The QualityStocks Daily Newsletter would like to spotlight Veritas Pharma, Inc. (VRTHF). Today, Veritas Pharma, Inc. closed trading at $0.68, up 6.20%, on 709,907 volume with 367 trades. The stock’s average daily volume over the past 60 days is 46,122 and its 52-week low/high is $0.171/$0.6528.

Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), announces its research arm, Cannevert Therapeutics Ltd. filed a provisional patent application to US Patent and Trademark Office on September 13, 2017 for use of a specific cannabis strain to enhance the actions of opioid analgesics.  An acknowledgement letter from the USPTO was received recently which provided a filing number of US 62/558,021 for this application.

Veritas Pharma, Inc. (CSE: VRT) (OTCQB: VRTHF) is an emerging pharmaceutical and IP development company publicly traded in Canada, the United States and Germany. Through its recently acquired 80 percent stake in Cannevert Therapeutics Ltd., also known as Veritas' R&D arm, the company is clinically profiling various marijuana cultivars to pharmacologically connect unique strains with specific disease conditions. Veritas Pharma's goal is to perform clinical trials to prove the efficacy of the designated lead cannabis strains and to market the clinically effective cultivars as prescription medicines in a fast-track protocol.

Veritas Pharma's management and R&D team comprises decades of pharmaceutical, clinical and scientific research expertise into several key industry leaders. Lui Franciosi, PhD, who has over 20 years of experience conducting pharmaceutical and medical device studies in academia and industry, leads the company as its CEO. In addition to a team of trained technicians and students working out of academic facilities, Veritas Pharma is pleased to have a renowned group of scientists on board to lead its research efforts. Team members hold 10 PhDs/MD licenses with expertise in chemistry, pharmacology and clinical trials.

Veritas Pharma's mission is to develop and commercialize the most effective cannabis strains, backed by clinical data. This innovative research and development path aims to solve the critical need for real science to support claims surrounding medical marijuana. The company's approach, combined with its strategic alliances, will effectively address the medical community's concerns over the complexities of cannabis potency, efficacy, quality and content in the nearly 800 marijuana strains currently known in the world. Opportunities for innovation and scientific advancement related to the field of cannabis therapeutics will accelerate the knowledge base and provide a valuable alternative to the global opioid market that is estimated at nearly U.S. $35 billion. A growing negative opinion regarding the use of opioids for pain will continue to drive the need for alternative medical applications such as those provided by cannabis.

Veritas Pharma's clinical cannabis development pipeline includes R&D for chronic pain, nausea, inflammation, muscle spasms, epilepsy and Post Traumatic Stress Disorder. The strategic alliance formed with Cannevert and its scientists will enable Veritas to be at the forefront of developing new and unique strains of medicinal cannabis. These plants, which they plan to patent protect for a variety of unmet medical needs, are destined to help patients suffering with chronic and debilitating symptoms of a variety of medical issues. Over 250 experiments have been performed so far with another 150 pharmacological and biological studies conducted. Veritas Pharma has also entered into an agreement with Sechelt Organic Marijuana Inc., which has a Licensed Producer application pending with Health Canada, to acquire 100 percent ownership in the company.

Results of the company's research to date illustrate Veritas' unique place in the medical marijuana industry. The company's focus on the biological effect of the actual spectrum of cannabinoids sets Veritas apart as it seeks to patent and protect results-driven strains. Disclaimer

Veritas Pharma, Inc. Blog

Veritas Pharma, Inc. News:

US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert

Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK

Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is “One to Watch”

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA). Today, Marijuana Company of America Inc. closed trading at $0.0271, up 0.37%, on 17,896,697 volume with 590 trades. The stock’s average daily volume over the past 60 days is 5,013,308 and its 52-week low/high is $0.0181/$0.114.

Marijuana Company of America Inc. (MCOA) an innovative hemp and cannabis corporation, is pleased to announce that it's joint venture partner, Bougainville Ventures, Inc., initiated construction on a 30,000 square foot cultivation facility in Washington state. The delivery of the first pre-designed greenhouses, with full tracking and reporting protocols, is expected to be completed this week for the I-502 facility. The site will eventually consist of 6 greenhouses providing a total of 30,000 sq. ft., of cultivation area. The construction is expected to be completed in February of 2018.

Marijuana Company of America Inc. (MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA's CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can also be used to produce products that are carbon neutral or even carbon negative, like the longest, strongest natural fiber on earth, building materials that are mold, pest and fire proof, super foods and so much more for additional business opportunities. No part of the plant is left unused and the Company's overall stategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented exponential growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015's $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal and cannabis and industrial hemp sectors. The Company's business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA's strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product "hempSMART Brain," is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience. Disclaimer

Marijuana Company of America Inc. Blog

Marijuana Company of America Inc. News:

Marijuana Company of America Provides Update on 30,000 Sq. Ft. Cultivation Facility in Washington State

Marijuana Company of America Completes Financing for Cultivation Facility in Washington State

NetworkNewsBreaks – Marijuana Company of America (MCOA) Delivers Distinctive Cannabis Investment Opportunities

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.1584, off by 4.00%, on 12,100 volume with 5 trades. The stock’s average daily volume over the past 60 days is 86,164 and its 52-week low/high is $0.0711/$0.2419.

Tapinator, Inc. (OTCQB: TAPM), a leading developer and publisher of mobile games on the iOS, Google Play and Amazon platforms, today announces that one of its recently launched Rapid-Launch Games, Virtual Mom: Happy Family 3D, published by and developed in collaboration with TapSim Game Studio, has become one of the Top 100 games in the U.S. on Google Play, according to AppAnnie.

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

Virtual Mom: Happy Family 3D Surges to Become a Top 100 Mobile Game on Google Play

Tapinator Releases Third Quarter 2017 Results

NetworkNewsWire Announces Publication on New Mobile Gaming Partnership in Profitable Field

Greenkraft, Inc. (GKIT)

The QualityStocks Daily Newsletter would like to spotlight Greenkraft, Inc. (GKIT). Today, Greenkraft, Inc. closed trading at $0.115, off by 4.17%, on 21,450 volume with 8 trades. The stock’s average daily volume over the past 60 days is 9,068 and its 52-week low/high is $0.02/$0.20.

Greenkraft, Inc. (OTCQB: GKIT), a nationally recognized player in the alternative fuel engine and vehicle market, announces the Company is receiving orders for its G-series trucks from Classes 4 to 7, positioning it to provide the commercial trucking industry with the only diesel alternative on the market Greenkraft's G-series trucks hold EPA and CARB certifications, have achieved near zero emissions classifications, and fill an immense void that exists in today's commercial truck industry as companies seek alternative fuel and gasoline options for fleet vehicles.

Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company's mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft's new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

"Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel," Gemayel states in a press release. "The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company's revenue in 2017."

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client's specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation's largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners. Disclaimer

Greenkraft, Inc. Blog

Greenkraft, Inc. News:

Greenkraft, Inc. (GKIT) Sees Jump in Sales for its Commercial Truck Line

Greenkraft, Inc. (OTCQB: GKIT) Signs Supply Contracts for its Alternative Fuel Commercial Trucks, Rising to Meet Industry Demand

Greenkraft, Inc.'s (GKIT) Alternative Fuel Engine Awarded Certification for Exceeding California's Clean Air Act Standards

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.019, even for the day, on 12,213,055 volume with 318 trades. The stock’s average daily volume over the past 60 days is 3,722,565, and its 52-week low/high is $0.009/$0.04.

Global Payout, Inc. (GOHE) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. has established a key strategic partnership with T&T Financial to shore-up and bolster the sales and marketing related services that MTRAC is delivering to many of the underserved businesses in the emerging cannabis industry.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

MoneyTrac Technology, Inc. Establishes Key Partnership to Strengthen Sales & Marketing of Its Alternative Banking Solutions

MoneyTrac Technology, Inc. Attends 2017 MJBizCon and Establishes Key Industry Connections for the Growth of the PotSaver Brand and Progress with the Development of Its Banking Solution

Global Payout’s MoneyTrac Technology, Inc. and Strategic Partner Pegasus Fintech, Inc. Move Closer to Launch of their Regulatory Complaint Token Offering for the Cannabis Industry

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(CIIX) +36.54%

2.

StockMarketWatch
(APEN) +32.68%

3.

Penny Stock Titans
(ETST) +32.14%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251